WHY IT MATTERS: Patients in Brazil and those watching international cannabis policy should know that new domestic cultivation rules could meaningfully expand access to locally produced, regulated cannabis medicines, potentially lowering costs and improving product consistency. CLINICAL OVERVIEW: Brazil’s updated cannabis regulatory framework represents a significant shift toward integrating medical cannabis into the formal healthcare system, including provisions for domestic cultivation under health authority oversight. The framework addresses THC-containing products more explicitly, which has direct implications for how physicians can recommend and patients can access a broader range of cannabinoid formulations.
Ghana launches medicinal cannabis programme under strict regulation
WHY IT MATTERS: For patients and clinicians globally, Ghana’s regulated medicinal cannabis program signals a growing international consensus that cannabis research deserves a legitimate scientific framework, which could accelerate cross-border data sharing and strengthen the overall evidence base for cannabis-based treatments. CLINICAL OVERVIEW: Ghana’s formal entry into medicinal cannabis programming represents a significant shift for West Africa, where regulatory frameworks for cannabis-based medicine have historically been absent or prohibitive. Structured research programs allow countries to generate population-specific clinical data, which is critical given that most existing evidence comes from Western or Israeli cohorts that may not reflect genetic, dietary, or disease-burden differences in sub-Saharan African populations.
DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency
WHY IT MATTERS: If the Philippines establishes a regulated medical cannabis program, patients in the country who currently have no legal access to cannabinoid therapies for conditions like chronic pain, epilepsy, or cancer-related symptoms could gain physician-supervised treatment options through a formal compassionate access pathway. CLINICAL OVERVIEW: The Philippine Department of Health is establishing conditions for a proposed medical cannabis legalization framework that would include compassionate access pathways for patients alongside expanded research initiatives and formal regulatory oversight. This approach mirrors the structured medical cannabis programs that have been successfully implemented in dozens of countries worldwide, where physician-supervised access is paired with robust safety monitoring.
The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook
WHY IT MATTERS: When countries like the Philippines move toward legalizing medical cannabis, it expands the global research landscape and may eventually improve the quality and diversity of clinical evidence that informs treatment protocols everywhere, including for patients currently under care. CLINICAL OVERVIEW: The Philippine House of Representatives is advancing legislative efforts through its committees on dangerous drugs and health to establish a medical cannabis framework for qualified patients, including a regulatory system and provisions for further research into therapeutic applications. This type of legislative movement in Southeast Asia reflects a broader global trend of countries reevaluating restrictive cannabis policies in light of mounting clinical evidence supporting cannabinoid therapies for conditions like chronic pain, epilepsy, and chemotherapy-induced nausea.